Cherry Slyder presents as an indica-dominant hybrid whose lineage runs through Northern Lights and Afghani. The resulting plant carries an earthy core complemented by a cherry sweetness and lifted by hints of pine and diesel. In aroma and flavor, the fruit-forward profile stands out, with the cherry note leading and a resinous backend that echoes the strain’s robust character.
Chemically, it carries a THC level near 19% with CBD around 0.13% and CBN near 0.52%. The effect tends toward a soothing body relaxation that can ease muscle tension and chronic pain, while also addressing nausea, insomnia, and anxiety for many patients. Importantly, users often report that it maintains mental clarity and a gentle psychoactive lift, enabling focus even as the body settles into calm.
Though often described as Indica-dominant, its roughly balanced heritage yields a versatile profile that suits different times and needs. The interplay of aromas—cherry, diesel, and pine—accompanies a flavor that fans out across the palate and lingers pleasantly. For those seeking appetite stimulation along with mood stabilization and a controlled sense of calm, Cherry Slyder offers a well-rounded option in the medical cannabis repertoire.